BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 14, 2006
View Archived Issues
Radius acquires rights to ER-beta selective compounds
Read More
Reimbursement progress for cintredekin besudotox
Read More
Series A financing at Cabrellis to fund development of Calsed
Read More
Second analytical method validated for PT-401
Read More
Neose Technologies receives research milestone payment from Novo Nordisk
Read More
QR-443 prevents cachexia in mice
Read More
rHuPH20 studied for absorption enhancement of large molecule protein therapeutic
Read More
Shire makes strides in second quarter
Read More
Phase I findings for AZD-103
Read More
Phase II trial of FM-VP4 on schedule
Read More
Combining immunotherapies with antitumor agents for the treatment of metastatic renal cell carcinoma
Read More
Second phase III trial of Sativex in central neuropathic pain due to MS
Read More
Biota receives award for development of Flunet compounds
Read More
Findings of investigation into patient death in phase II DAC:GRF trial
Read More
Withdrawal of E.U. marketing authorization for Fortovase
Read More
WX-671 begins study in cancer patients
Read More
Epigenomics enters into R&D agreement with J&J
Read More
Immunicon enters into agreements with AstraZeneca
Read More
Homer-1a: a novel target for pain therapeutics
Read More
Novel therapeutic agents for respiratory disorders disclosed in recent patents
Read More
New therapeutic agents for metabolic disorders reported in recent patent literature
Read More
Novel P2Y1 receptor antagonists for thrombotic disorders emerge from Bristol-Myers Squibb R&D
Read More
Activation of EGFR in optic nerve astrocytes mediates optic nerve damage in rats
Read More
Augmentation strategy with memantine for resistant depression to be evaluated in clinical study
Read More
Ophthalmic ciclosporin to be tested for the treatment of ocular rosacea in new clinical trial
Read More
